Time to blood pressure control and predictors among patients receiving integrated treatment for hypertension and HIV based on an adapted WHO HEARTS implementation strategy at a large urban HIV clinic in Uganda
Authors:
Preprint
- 15 March 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
In this cohort study, we determined time to blood pressure (BP) control and its predictors among hypertensive PLHIV enrolled in integrated hypertension-HIV care based on the World Health Organization (WHO) HEARTS strategy at Mulago Immunosuppression Clinic in Uganda. From August 2019 to March 2020, we enrolled hypertensive PLHIV aged \(\ge\)18 years and initiated Amlodipine 5mg mono-therapy for BP (140–159)/(90–99) mmHg or Amlodipine 5mg/Valsartan 80mg duo-therapy for BP ≥ 160/90mmHg. Patients were followed with a treatment escalation plan until BP control, defined as BP < 140/90 mmHg. We used Cox proportional hazards models to identify predictors of time to BP control. Of 877 PLHIV enrolled (mean age 50.4 years, 62.1% female), 30% received mono-therapy and 70% received duo-therapy. In the monotherapy group, 66%, 88% and 96% attained BP control in the first, second and third months, respectively. For patients on duo-therapy, 56%, 83%, 88% and 90% achieved BP control in the first, second, third, and fourth months, respectively. In adjusted Cox proportional hazard analysis, higher systolic BP (aHR 0.995, 95% CI 0.989–0.999) and baseline ART tenofovir/lamivudine/efavirenz (aHR 0.764, 95% CI 0.637–0.917) were associated with longer time to BP control, while being on ART for > 10 years was associated with a shorter time to BP control (aHR 1.456, 95% CI 1.126–1.883). The WHO HEARTS strategy was effective at achieving timely BP control among PLHIV. Additionally, monotherapy anti-hypertensive treatment for stage I hypertension is a viable option to achieve BP control and limit pill burden in resource limited HIV care settings.
Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Improved hypertension control at six months using an adapted WHO HEARTS-based implementation strategy at a large urban HIV clinic in UgandaBMC Health Services Research, 2022
- Experience of chronic noncommunicable disease in people living with HIV: a systematic review and meta-aggregation of qualitative studiesBMC Public Health, 2021
- Integrating care for non‐communicable diseases into routine HIV services: key considerations for policy design in sub‐Saharan AfricaJournal of the International AIDS Society, 2020
- Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH studyBMC Public Health, 2019
- Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan AfricaAIDS, 2018
- Hypertension in HIV-Infected AdultsHypertension, 2018
- Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysisJournal of Human Hypertension, 2015
- Time to Achieve First Blood Pressure Control After Diagnosis Among Hypertensive Patients at Primary Health Care ClinicsAsia Pacific Journal of Public Health, 2013
- Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysisBMJ, 2011
- Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 TrialsThe American Journal of Medicine, 2009